bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.11.06.687002

Post-admixture selection favours Duffy negativity in the Lower Okavango Basin

Abstract

The FY*BES allele in the human Duffy blood group is nearly fixed across much of sub-Saharan Africa. Individuals homozygous for this allele (Duffy-negative) were considered resistant to red blood cell invasion by the malaria parasite Plasmodium vivax, restricting its distribution across the continent. However, as recent studies have demonstrated that P. vivax can infect Duffy-negative individuals and is widespread among African populations where FY*BES predominates, long-standing assumptions about the evolutionary relationship between Duffy negativity and parasite resistance should be re-evaluated across diverse geographic, ecological and epidemiological settings. Previous research investigating the role of natural selection in increasing the frequency of the FY*BES allele has primarily centered on admixed populations with African and non-African ancestries from regions with long-documented P. vivax transmission. Here, we focus on the Khwe foragers from the lower Okavango River Basin, where the parasite has only recently been reported. Using locus-specific statistics, simulations of neutral scenarios, and local ancestry inference, we found strong evidence for post-admixture selection promoting FY*BES introgression from Bantu-speaking populations into the Khwe. If P. vivax resistance indeed drove the rise in FY*BES allele frequency, our findings suggest that the parasite has been present in the region at least 500 to 1,000 years ago.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kasianov, A., Fehn, A.-M., Bolaane, M., Masunga, G., Fabiano, E. C., Rocha, J.. 2025-11-07. Post-admixture selection favours Duffy negativity in the Lower Okavango Basin. https://doi.org/10.1101/2025.11.06.687002

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗